Antibody specialist Genmab has continued its shift from out-licensing drugs to developing its own medicines with a deal to buy Merus and its lead drug candidate for head and neck cancer for around $8 ...
Always a big player in oncology, Eli Lilly has fallen behind some of its rivals when it comes to cancer immunotherapy, but a new R&D alliance with Dutch biotech Merus is further evidence of its ...
Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2021, EDGAR®Online, a division of Donnelley Financial Solutions ...
Overseas Adventure Travel provides small group travel and adventure tours. Focusing on destinations that are off the beaten path. The company offers itineraries that include opportunities for cultural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results